Emily Kendall

Emily Kendall, MD, PhD, is an Associate Professor of Medicine in the Division of Infectious Diseases at the Johns Hopkins University School of Medicine. She is affiliated with the Center for Tuberculosis Research and is actively involved in clinical and epidemiological research focused on tuberculosis.

Educational Background:

• B.A., Harvard University
• M.D., Vanderbilt University School of Medicine
• Residency, Internal Medicine, Massachusetts General Hospital
• Fellowship, Infectious Diseases, Johns Hopkins University
• PhD, Johns Hopkins Bloomberg School of Public Health (2018)

Her research integrates clinical data with mechanistic and computational modeling to address key challenges in tuberculosis transmission, diagnostics, and treatment optimization. She has contributed extensively to global health discussions through publications in high-impact journals such as The Lancet and Clinical Infectious Diseases. Her recent work emphasizes cost-effectiveness of pan-TB regimens, subclinical tuberculosis, and equity-centered approaches to TB elimination.

Dr. Kendall's publications reflect a strong focus on modeling infectious disease dynamics, evaluating novel treatment strategies, and shaping public health policy. Her work frequently addresses the epidemiological and economic dimensions of tuberculosis control, with implications for global health policy and clinical practice.

Scientific Contributions:

• Principal investigator for clinical trials in tuberculosis
• Contributor to WHO guidelines on TB treatment regimens
• Advocate for improved detection and care of subclinical and pediatric TB

She is board certified in Internal Medicine and Infectious Disease by the American Board of Internal Medicine. Dr. Kendall sees patients at The Johns Hopkins Hospital and is accepting new patients. Her research is supported by her role within the Center for Tuberculosis Research, where she leads modeling and epidemiological studies to inform public health priorities.